通过多组织数据集成来发现孕前和妊娠高血压的治疗点
Hang Yao1, Jiahao Chen2, Yu Wang3
1School of Traditional Chinese Medicine, Binzhou Medical University, Yantai, China.
BMC pregnancy and childbirth
|April 24, 2025
概括
这项研究使用遗传数据确定了先兆子 (PE) 和妊娠高血压 (PH) 的新疗法标. 这些发现为这些严重的妊娠并发症的共同机制和潜在治疗方法提供了新的见解.
科学领域:
- 产科和妇科 产科和妇科
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 孕前 (PE) 和妊娠高血压 (PH) 是严重的妊娠并发症,对母亲和胎儿有严重的后果.
- 确定新的治疗目标对于开发PE和PH的有效治疗策略至关重要.
研究的目的:
- 为了确定潜在的基因治疗对象为先兆子 (PE) 和妊娠高血压 (PH).
- 探索PE和PH背后的共同遗传机制.
- 为未来的治疗开发提供基础数据.
主要方法:
- 使用基于总结数据的门德尔随机化 (SMR) 分析.
- 综合表达定量特征位点 (eQTL) 数据 (血液,大动脉,子宫,脏) 与全基因组关联研究 (GWAS) 数据对PE和PH.
- 采用HEIDI和FDR进行统计严谨;遵循STROBE-MR指南.
主要成果:
- 通过整合PE和PH的多组织eQTL和GWAS数据,确定了几个潜在的治疗点.
- 在PE和PH中发现了具有共同作用的基因,表明共享的病理途径.
- 提供了对这些疾病的病原体的新见解.
结论:
- 揭示了PE和PH的多个潜在治疗点.
- 为基础研究和临床干预提供了新的见解,以减少PE和PH的影响.
相关概念视频
Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
Hypertension and Regulation of Blood Pressure
1.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.8K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
85
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
85


